Phuahana kiko'ī:
| Ka nana aku | keʻokeʻo i ka pauka keʻokeʻo |
| Ka hoʻololi kikoʻī (a)D20(C=8 ma 6N HCl)) | +23º a +25º |
| L-Valine | ʻAʻole ma mua o 0.1% |
| L-Leucine | ʻAʻole ma mua o 0.1% |
| L-Norleucine | ʻAʻole ma mua o 0.1% |
| Ka lawe ʻana | ʻAʻole emi ma lalo o 98.0% |
| Pohō ma ka maloʻo | ʻAʻole ʻoi aku ma mua o 0.2% |
| Ke koena ma ka ʻā | ʻAʻole ma mua o 0.1% |
| PH | 5.6-6.5 |
| Hoʻāʻo | 98.0-101.0% |
| Nā ʻakika amino ʻē aʻe | ʻAʻole iʻoi aku ma mua o 0.5% |
| Pūʻolo | 25kg/ pahu |
| Manawa mana | 2 makahiki |
| Kaʻahele | ma ke kai a ma ka lewa a ma ka ʻāina |
| ʻĀina i kumu | Kina |
| ʻŌlelo uku | T/T |
Nā huaʻōlelo like：
L-2-AMinopentanoic-d5 Acid;
L-Norvalinearginase inhibitor;
L-Novvaline;
Norvaline
H-Nva-OH;
H-Nva-OH(L-Norvaline);
L(+)-Norvaline, 99% 1GR;
L-Norvaline, 97+%;
HL-NORVALINE
Palapala noi：
Hiki ke hoʻohana ʻia ʻo L-Norvaline no ka synthesis o nā meaʻai a me nā lāʻau lapaʻau.
Kiekie:
1. Loaʻa iā mākou ka pae ton i ka waihona, a hiki iā mākou ke hāʻawi koke i ka mea ma hope o ka loaʻa ʻana o ke kauoha.
2. Hiki ke hāʻawi ʻia ke kumukūʻai kiʻekiʻe & hoʻokūkū.
3.Quality analysis report (COA) o ka pahu hoʻouna e hāʻawi ʻia ma mua o ka hoʻouna ʻana.
4. Hiki ke hā'awi 'ia ka nīnau nīnau mea kū'ai a me nā palapala 'ike loea inā noi ma hope o ka hālāwai 'ana i kekahi huina.
5. Nui ma hope o ke kūʻai aku a hōʻoiaʻiʻo paha: E hoʻoponopono koke ʻia kekahi o kāu nīnau.
6. E hoʻokuʻu aku i nā huahana hoʻokūkū a hoʻokuʻu aku iā lākou i waho i nā mea nui i kēlā me kēia makahiki.
